Inactive Instrument
Sector Ariad Pharmaceuticals, Inc.
Stocks
US04033A1007
Biotechnology & Medical Research
|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 17-01-10 | Takeda Pharmaceutical : Japan's Takeda ready for fresh acquisitions after $5.2 billion Ariad deal | RE |
| 14-06-02 | Dai ichi Life Insurance : U.S. futures flat with Dow, S&P at record levels | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | - | - | - | - | - | 0 | |
| +5.04% | +3.27% | -2.14% | +59.32% | +75.26% | +50.62% | +105.43% | +16.53% | - | 66.93B | |
| +1.64% | -2.89% | +15.03% | +10.75% | +21.07% | +34.67% | +80.49% | +215.68% | +5,647.02% | 61.97B | |
| -3.18% | +0.15% | +1.08% | +28.34% | -28.13% | -12.62% | +368.99% | +358.17% | +800.50% | 28.26B | |
| +4.55% | -0.08% | +7.48% | +58.11% | +56.30% | +34.70% | +17.28% | -57.34% | - | 24.59B | |
| +2.23% | +0.16% | +6.16% | +8.83% | +3.80% | +0.96% | -13.17% | -70.49% | - | 24.3B | |
| +1.15% | -2.26% | +4.49% | +30.70% | +4.39% | +17.56% | -16.53% | -24.27% | +106.44% | 19.41B | |
| -7.03% | -9.16% | -17.65% | +39.10% | +180.86% | +161.91% | +303.00% | +1,410.20% | +722.97% | 16.77B | |
| +3.44% | -1.68% | -8.43% | +15.90% | +22.69% | -5.00% | +541.17% | - | - | 14.18B | |
| +4.99% | +6.51% | +37.87% | +30.25% | +5.23% | -2.82% | +863.61% | +187.58% | +194.48% | 14B | |
| +0.20% | -2.65% | +9.56% | +5.92% | +28.09% | +43.91% | +152.09% | +178.89% | +331.51% | 13.91B | |
| +0.99% | +1.15% | +6.45% | +8.11% | -7.22% | +26.95% | +208.14% | +582.37% | +5,125.34% | 12.35B | |
| -2.64% | -5.31% | -6.98% | +4.46% | +21.39% | +181.10% | +163.88% | +28.90% | +1,041.50% | 11.7B | |
| +5.98% | -5.43% | -7.63% | +4.02% | -15.31% | -29.37% | +163.64% | +124.38% | - | 10.61B | |
| -2.74% | +7.24% | +16.57% | +40.24% | +258.89% | +85.28% | +22.52% | -92.60% | - | 10.32B | |
| -1.80% | -3.75% | -2.17% | +1.60% | +14.14% | +46.69% | +112.00% | +119.11% | +713.06% | 10.26B | |
| +0.17% | -1.57% | +2.31% | +19.87% | +28.76% | +91.65% | +15.36% | +129.21% | - | 8.85B | |
| +5.06% | +0.54% | +10.11% | +16.90% | +320.96% | +204.20% | +393.20% | -10.76% | - | 8.38B | |
| +3.05% | -5.00% | -7.88% | +1.95% | +5.56% | -30.53% | +100.00% | -25.71% | - | 8B | |
| +0.14% | +0.12% | -12.29% | +8.75% | +177.46% | +512.50% | +551.58% | -47.99% | -55.17% | 7.99B | |
| Average | +2.81% | -3.08% | +2.73% | +20.69% | +61.80% | +74.33% | +217.51% | +167.88% | +1,462.77% | 18.64B | |
| Weighted average by Cap. | +2.51% | -2.72% | +4.02% | +27.08% | +48.70% | +52.27% | +175.60% | +165.49% | +2,423.31% |
- Stock Market
- Stocks
- Stock
- Sector Ariad Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
